Sign inJoin waitlistJoin the waitlist

Joan Walker

Professor, Section of Gynecologic Oncology · University of Oklahoma College of Medicine

Credentials: · · · ·

History

University of Oklahoma College of Medicine
Present

Gynecologic Oncology
University of California in Irvine
1986–1989
University of Pennsylvania
1982–1986
UCLA David Geffen School of Medicine
1978–1982

Research

Intraperitoneal cisplatin and paclitaxel in ovarian cancer
New England Journal of Medicine · 2006 · 2,043 citations
Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
New England Journal of Medicine · 1999 · 1,518 citations
Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2
Journal of Clinical Oncology · 2009 · First of 10 authors · Corresponding · 932 citations

Robert Mannel
51 papers · 3 as a fellow
Michael Gold
50 papers · 8 as a fellow
RZ
Rosemary Zuna
43 papers
Kathleen Moore
27 papers · 15 as a resident
DM
Donald Mcmeekin
24 papers
Bradley Monk
19 papers · 2 as a resident
David Cohn
19 papers · 2 as a fellow
PD
Paul DiSilvestro
19 papers
Krishnansu Tewari
18 papers
Lisa Landrum
16 papers · 11 as a resident
CM
Cara Mathews
15 papers · 8 as a resident
Deborah Armstrong
14 papers

Grants

Stephenson Cancer Center - Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $275.5K · University of Oklahoma Hlth Sciences Ctr
2018–2028
NRG Oncology NCORP Research Base
National Cancer Institute · UG1
PI · $99.2M · Nrg Oncology Foundation, Inc.
2014–2026
A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials
National Cancer Institute · UG1
PI · $8.9M · University of Oklahoma Hlth Sciences Ctr
2019–2025
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $454.2K · University of Oklahoma Hlth Sciences Ctr
2004–2007

Clinical trials

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Principal investigator · Completed · Phase 3
National Cancer Institute (NCI)
2009–2016
Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
Principal investigator · Terminated · Phase 2
University of Oklahoma
2006–2011
Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2004
Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer
Study chair · Completed · Phase 1, Phase 2
Gynecologic Oncology Group
1999